Literature DB >> 8237312

Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990.

H Malchau1, P Herberts, L Ahnfelt.   

Abstract

A prospective, national multi-center study of all reoperations after total hip replacement (THR) was started by the Swedish Orthopedic Association in 1979. The material comprises all THR performed in Sweden, presently more than 10,000 yearly or 130 THR per 100,000 inhabitants; uncemented implants have been used in less than 2 percent. The main reasons for revision have been aseptic loosening 79 percent, infection 10 percent, technical error 6 percent, and dislocation 2 percent. The cumulative rate of revision for deep infection has dropped from 0.9 percent to < 0.5 percent for implants inserted 1979 and 1983, respectively. With the Charnley prosthesis as the gold, standard the performance of other prostheses was analyzed. Improved cementation techniques and anti-infection measures have continuously reduced the revision risk. The register demonstrates that the average orthopedic surgeon cannot match the results achieved by experts. However, the vast majority of THR, worldwide, are not performed by experts. Quality-assurance in this sector of orthopedics demands a continuous analysis of the outcome of these operations.

Entities:  

Mesh:

Year:  1993        PMID: 8237312     DOI: 10.3109/17453679308993679

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  78 in total

1.  An economic model to estimate the relative costs over 20 years of different hip prostheses.

Authors:  K Baxter; G Bevan
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

2.  How long should patients be followed-up after total hip replacement? Current practice in the UK.

Authors:  M J Bankes; R Coull; B D Ferris
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

3.  Revision hip arthroplasty activity in a single UK health region: an audit of 1265 cases.

Authors:  T Hassan; S Birtwistle; R A Power; W M Harper
Journal:  Ann R Coll Surg Engl       Date:  2000-07       Impact factor: 1.891

4.  Failure patterns of four osseointegrated oral implant systems.

Authors:  M Esposito; J M Hirsch; U Lekholm; P Thomsen
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

5.  Subsidence of a cementless femoral component influenced by body weight and body mass index.

Authors:  Christoph Stihsen; Roman Radl; Armin Keshmiri; Peter Rehak; Reinhard Windhager
Journal:  Int Orthop       Date:  2011-11-04       Impact factor: 3.075

6.  Kaiser Permanente National Total Joint Replacement Registry: aligning operations with information technology.

Authors:  Elizabeth W Paxton; Maria C S Inacio; Monti Khatod; Eric J Yue; Robert S Namba
Journal:  Clin Orthop Relat Res       Date:  2010-10       Impact factor: 4.176

7.  Choice of hospital for revision total hip replacement.

Authors:  Jeffrey N Katz; Elizabeth A Wright; John Wright; Kelly L Corbett; Henrik Malchau; John A Baron; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2010-12-01       Impact factor: 5.284

8.  The 2013 Frank Stinchfield Award: Diagnosis of infection in the early postoperative period after total hip arthroplasty.

Authors:  Paul H Yi; Michael B Cross; Mario Moric; Scott M Sporer; Richard A Berger; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

9.  Anatomically shaped tissue-engineered cartilage with tunable and inducible anticytokine delivery for biological joint resurfacing.

Authors:  Franklin T Moutos; Katherine A Glass; Sarah A Compton; Alison K Ross; Charles A Gersbach; Farshid Guilak; Bradley T Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

10.  Extreme variations in racial rates of total hip arthroplasty for primary coxarthrosis: a population-based study in San Francisco.

Authors:  F T Hoaglund; C S Oishi; G G Gialamas
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.